Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions · 2026
Comparison of Immediate Versus Staged Complete Revascularization in Patients With Index PCI Coronary Complications: A Study on Clinical Outcomes and Predictors of Complications.
СтатьяНазвание и аннотация: Перевод пока не подготовлен
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Gabrielli Alessandro, Elscot Jacob J, Camilleri William, Kakar Hala, Boersma Eric, Mieghem Nicolas M Van, Diletti Roberto, Dekker Wijnand K Den
Аннотация
BACKGROUND: In patients with acute coronary syndrome (ACS) and multivessel disease (MVD), complete revascularization (CR) improves clinical outcomes compared with culprit-only percutaneous coronary intervention (PCI). However, the optimal timing of CR, immediate (ICR) versus staged (SCR), remains debated.
AIMS: This post hoc analysis of the BIOVASC trial aimed to evaluate whether unresolved culprit-lesion-related complications influence outcomes of ICR compared with SCR and to identify predictors of procedural complications.
METHODS: Among 1525 patients enrolled in BIOVASC, 1487 index coronary angiographies were analyzed. Coronary complications related to culprit lesion PCI were classified and assessed for resolution status. Clinical outcomes were evaluated at 2-year follow-up according to randomized treatment strategy (ICR vs. SCR). Logistic regression was used to identify independent predictors of complications.
RESULTS: Culprit-lesion-related complications occurred in 153 of 1487 procedures (10.3%), with 125 (81.7%) unresolved at the end of the index procedure. The most frequent complications were side branch occlusion or slow flow and distal slow reflow. Among patients with unresolved complications, the 2-year rate of major adverse cardiovascular events (MACE: death, myocardial infarction, unplanned revascularization, or stroke) was similar between ICR and SCR (10.6% vs. 17.2%; HR 0.58, 95% CI 0.22-1.52; p = 0.27). Independent predictors of procedural complications were complex culprit lesion morphology (class B2/C) (OR 1.68, 95% CI 1.07-2.63; p = 0.023) and STEMI presentation (OR 1.45, 95% CI 1.00-2.11; p = 0.049).
CONCLUSIONS: In patients with unresolved culprit lesion complications during index PCI, ICR showed comparable 2-year outcomes to the staged approach. Complex lesion morphology and STEMI presentation independently predicted procedural complications. These findings suggest that ICR remains a safe and viable strategy in hemodynamically stable patients, even in the presence of procedural challenges.
AIMS: This post hoc analysis of the BIOVASC trial aimed to evaluate whether unresolved culprit-lesion-related complications influence outcomes of ICR compared with SCR and to identify predictors of procedural complications.
METHODS: Among 1525 patients enrolled in BIOVASC, 1487 index coronary angiographies were analyzed. Coronary complications related to culprit lesion PCI were classified and assessed for resolution status. Clinical outcomes were evaluated at 2-year follow-up according to randomized treatment strategy (ICR vs. SCR). Logistic regression was used to identify independent predictors of complications.
RESULTS: Culprit-lesion-related complications occurred in 153 of 1487 procedures (10.3%), with 125 (81.7%) unresolved at the end of the index procedure. The most frequent complications were side branch occlusion or slow flow and distal slow reflow. Among patients with unresolved complications, the 2-year rate of major adverse cardiovascular events (MACE: death, myocardial infarction, unplanned revascularization, or stroke) was similar between ICR and SCR (10.6% vs. 17.2%; HR 0.58, 95% CI 0.22-1.52; p = 0.27). Independent predictors of procedural complications were complex culprit lesion morphology (class B2/C) (OR 1.68, 95% CI 1.07-2.63; p = 0.023) and STEMI presentation (OR 1.45, 95% CI 1.00-2.11; p = 0.049).
CONCLUSIONS: In patients with unresolved culprit lesion complications during index PCI, ICR showed comparable 2-year outcomes to the staged approach. Complex lesion morphology and STEMI presentation independently predicted procedural complications. These findings suggest that ICR remains a safe and viable strategy in hemodynamically stable patients, even in the presence of procedural challenges.